1.Validation of the Patient Health Questionnaire–9 and Patient Health Questionnaire–2 in the General Korean Population
Minah KIM ; Sanghyup JUNG ; Jee Eun PARK ; Jee Hoon SOHN ; Su Jeong SEONG ; Byung-Soo KIM ; Sung Man CHANG ; Jin Pyo HONG ; Bong-Jin HAHM ; Chan-Woo YEOM
Psychiatry Investigation 2023;20(9):853-860
Objective:
The Patient Health Questionnaire–9 (PHQ-9) and PHQ-2 have not been validated in the general Korean population. This study aimed to validate and identify the optimal cutoff scores of the PHQ-9 and PHQ-2 in screening for major depression in the general Korean population.
Methods:
We used data from 6,022 participants of the Korean Epidemiological Catchment Area Study for Psychiatric Disorders in 2011. Major depression was diagnosed according to the Korean Composite International Diagnostic Interview. Validity, reliability, and receiver operating characteristic curve analyses were performed using the results of the PHQ-9 and Euro Quality of life-5 dimension (EQ-5d).
Results:
Of the 6,022 participants, 150 were diagnosed with major depression (2.5%). Both PHQ-9 and PHQ-2 demonstrated relatively high reliability and their scores were highly correlated with the “anxiety/depression” score of the EQ-5d. The optimal cutoff score of the PHQ-9 was 5, with a sensitivity of 89.9%, specificity of 84.1%, positive predictive value (PPV) of 12.6%, negative predictive value (NPV) of 99.7%, positive likelihood ratio (LR+) of 5.6, and negative likelihood ratio (LR-) of 0.12. The optimal cutoff score of the PHQ-2 was 2, with a sensitivity of 85.3%, specificity of 83.2%, PPV of 11.6%, NPV of 99.5%, LR+ of 5.1, and LR- of 0.18.
Conclusion
The PHQ-9 and PHQ-2 are valid tools for screening major depression in the general Korean population, with suggested cutoff values of 5 and 2 points, respectively.
2.Laboratory information management system for COVID-19 non-clinical efficacy trial data
Suhyeon YOON ; Hyuna NOH ; Heejin JIN ; Sungyoung LEE ; Soyul HAN ; Sung-Hee KIM ; Jiseon KIM ; Jung Seon SEO ; Jeong Jin KIM ; In Ho PARK ; Jooyeon OH ; Joon-Yong BAE ; Gee Eun LEE ; Sun-Je WOO ; Sun-Min SEO ; Na-Won KIM ; Youn Woo LEE ; Hui Jeong JANG ; Seung-Min HONG ; Se-Hee AN ; Kwang-Soo LYOO ; Minjoo YEOM ; Hanbyeul LEE ; Bud JUNG ; Sun-Woo YOON ; Jung-Ah KANG ; Sang-Hyuk SEOK ; Yu Jin LEE ; Seo Yeon KIM ; Young Been KIM ; Ji-Yeon HWANG ; Dain ON ; Soo-Yeon LIM ; Sol Pin KIM ; Ji Yun JANG ; Ho LEE ; Kyoungmi KIM ; Hyo-Jung LEE ; Hong Bin KIM ; Jun Won PARK ; Dae Gwin JEONG ; Daesub SONG ; Kang-Seuk CHOI ; Ho-Young LEE ; Yang-Kyu CHOI ; Jung-ah CHOI ; Manki SONG ; Man-Seong PARK ; Jun-Young SEO ; Ki Taek NAM ; Jeon-Soo SHIN ; Sungho WON ; Jun-Won YUN ; Je Kyung SEONG
Laboratory Animal Research 2022;38(2):119-127
Background:
As the number of large-scale studies involving multiple organizations producing data has steadily increased, an integrated system for a common interoperable format is needed. In response to the coronavirus disease 2019 (COVID-19) pandemic, a number of global efforts are underway to develop vaccines and therapeutics. We are therefore observing an explosion in the proliferation of COVID-19 data, and interoperability is highly requested in multiple institutions participating simultaneously in COVID-19 pandemic research.
Results:
In this study, a laboratory information management system (LIMS) approach has been adopted to systemically manage various COVID-19 non-clinical trial data, including mortality, clinical signs, body weight, body temperature, organ weights, viral titer (viral replication and viral RNA), and multiorgan histopathology, from multiple institutions based on a web interface. The main aim of the implemented system is to integrate, standardize, and organize data collected from laboratories in multiple institutes for COVID-19 non-clinical efficacy testings. Six animal biosafety level 3 institutions proved the feasibility of our system. Substantial benefits were shown by maximizing collaborative high-quality non-clinical research.
Conclusions
This LIMS platform can be used for future outbreaks, leading to accelerated medical product development through the systematic management of extensive data from non-clinical animal studies.
3.Association Between Body Mass Index and Cognitive Function in Mild Cognitive Impairment Regardless of APOE ε4 Status
Ye Sol MUN ; Hee Kyung PARK ; Jihee KIM ; Jiyoung YEOM ; Geon Ha KIM ; Min Young CHUN ; Hye Ah LEE ; Soo Jin YOON ; Kyung Won PARK ; Eun-Joo KIM ; Bora YOON ; Jae-Won JANG ; Jin Yong HONG ; Seong Hye CHOI ; Jee Hyang JEONG
Dementia and Neurocognitive Disorders 2022;21(1):30-41
Background:
and Purpose: In this study we aimed to find the association between neuropsychological performance and body mass index (BMI) in patients with mild cognitive impairment (MCI). In addition, we investigated the effects of the apolipoprotein E (APOE) genotype in the relationship between the BMI and cognition in MCI.
Methods:
We enrolled a cohort of 3,038 subjects with MCI aged 65–90 from the Clinical Research Center for Dementia of South Korea and a dementia cohort of the Ewha Womans University Mokdong Hospital. MCI patients were classified into three subgroups according to the Asian standard of BMI. We compared cognitive performances between groups by one-way analysis of variance. To investigate the effects of the APOE genotype, we used multivariate linear regression models after adjusting for possible confounders.
Results:
Even though normal BMI groups were younger, had more females, and had less comorbidities, the higher BMI groups had better cognitive functions. Among subjects with APOE ε4 carriers, there was a positive relationship between the BMI and the memory task alone.
Conclusions
Our findings suggested that higher BMI in patients with MCI were associated with better cognitive performance. The effects of the APOE ε4 genotype in the associations between BMI and cognition were distinguishing. Therefore, according to physical status, APOE ε4 genotype-specific strategies in the assessments and treatments may be necessary in elderly patients with MCI.
4.2020 Korean Guidelines for Cardiopulmonary Resuscitation. Part 7. Pediatric advanced life support
Yu Hyeon CHOI ; Do Kyun KIM ; Eun Kyeong KANG ; Jin-Tae KIM ; Jae Yoon NA ; Bobae PARK ; Seok Ran YEOM ; Joo Suk OH ; Jisook LEE ; Won Kyoung JHANG ; Soo In JEONG ; Jin Hee JUNG ; Jea Yeon CHOI ; June Dong PARK ; Sung Oh HWANG ;
Clinical and Experimental Emergency Medicine 2021;8(S):S81-S95
5.2020 Korean Guidelines for Cardiopulmonary Resuscitation. Part 6. Pediatric basic life support
Jisook LEE ; Do Kyun KIM ; Eun Kyeong KANG ; Jin-Tae KIM ; Jae Yoon NA ; Bobae PARK ; Seok Ran YEOM ; Joo Suk OH ; Won Kyoung JHANG ; Soo In JEONG ; Jin Hee JUNG ; Yu Hyeon CHOI ; Jea Yeon CHOI ; June Dong PARK ; Sung Oh HWANG ;
Clinical and Experimental Emergency Medicine 2021;8(S):S65-S80
6.2020 Korean Guidelines for Cardiopulmonary Resuscitation. Part 7. Pediatric advanced life support
Yu Hyeon CHOI ; Do Kyun KIM ; Eun Kyeong KANG ; Jin-Tae KIM ; Jae Yoon NA ; Bobae PARK ; Seok Ran YEOM ; Joo Suk OH ; Jisook LEE ; Won Kyoung JHANG ; Soo In JEONG ; Jin Hee JUNG ; Jea Yeon CHOI ; June Dong PARK ; Sung Oh HWANG ;
Clinical and Experimental Emergency Medicine 2021;8(S):S81-S95
7.2020 Korean Guidelines for Cardiopulmonary Resuscitation. Part 6. Pediatric basic life support
Jisook LEE ; Do Kyun KIM ; Eun Kyeong KANG ; Jin-Tae KIM ; Jae Yoon NA ; Bobae PARK ; Seok Ran YEOM ; Joo Suk OH ; Won Kyoung JHANG ; Soo In JEONG ; Jin Hee JUNG ; Yu Hyeon CHOI ; Jea Yeon CHOI ; June Dong PARK ; Sung Oh HWANG ;
Clinical and Experimental Emergency Medicine 2021;8(S):S65-S80
8.Sputum Processing Method for Lateral Flow Immunochromatographic Assays to Detect Coronaviruses
Aram KANG ; Minjoo YEOM ; Hyekwon KIM ; Sun-Woo YOON ; Dae-Gwin JEONG ; Hyong-Joon MOON ; Kwang-Soo LYOO ; Woonsung NA ; Daesub SONG
Immune Network 2021;21(1):e11-
Coronavirus causes an infectious disease in various species and crosses the species barriers leading to the outbreak of zoonotic diseases. Due to the respiratory diseases are mainly caused in humans and viruses are replicated and excreted through the respiratory tract, the nasal fluid and sputum are mainly used for diagnosis. Early diagnosis of coronavirus plays an important role in preventing its spread and is essential for quarantine policies. For rapid decision and prompt triage of infected host, the immunochromatographic assay (ICA) has been widely used for point of care testing. However, when the ICA is applied to an expectorated sputum in which antigens are present, the viscosity of sputum interferes with the migration of the antigens on the test strip. To overcome this limitation, it is necessary to use a mucolytic agent without affecting the antigens. In this study, we combined known mucolytic agents to lower the viscosity of sputum and applied that to alpha and beta coronavirus, porcine epidemic diarrhea virus (PEDV) and Middle East respiratory syndrome coronavirus (MERS-CoV), respectively, spiked in sputum to find optimal pretreatment conditions. The pretreatment method using tris(2-carboxyethyl)phosphine (TCEP) and BSA was suitable for ICA diagnosis of sputum samples spiked with PEDV and MERS-CoV. This sensitive assay for the detection of coronavirus in sputum provides an useful information for the diagnosis of pathogen in low respiratory tract.
9.Identification of Fungal Species and Detection of Azole-Resistance Mutations in the Aspergillus fumigatus cyp51A Gene at a South Korean Hospital
In Young JUNG ; Youn-Jung LEE ; Hyo Sup SHIM ; Yun Suk CHO ; Yu Jin SOHN ; Jong Hoon HYUN ; Yae Jee BAEK ; Moo Hyun KIM ; Jung Ho KIM ; Jin Young AHN ; Su Jin JEONG ; Nam Su KU ; Yoon Soo PARK ; Joon Sup YEOM ; Young Keun KIM ; Hyo Youl KIM ; Jun Yong CHOI
Yonsei Medical Journal 2020;61(8):698-704
Purpose:
With changing fungal epidemiology and azole resistance in Aspergillus species, identifying fungal species and susceptibility patterns is crucial to the management of aspergillosis and mucormycosis. The objectives of this study were to evaluate performance of panfungal polymerase chain reaction (PCR) assays on formalin-fixed paraffin embedded (FFPE) samples in the identification of fungal species and in the detection of azole-resistance mutations in the Aspergillus fumigatus cyp51A gene at a South Korean hospital.
Materials and Methods:
A total of 75 FFPE specimens with a histopathological diagnosis of aspergillosis or mucormycosis were identified during the 10-year study period (2006–2015). After deparaffinization and DNA extraction, panfungal PCR assays were conducted on FFPE samples for fungal species identification. The identified fungal species were compared with histopathological diagnosis. On samples identified as A. fumigatus, sequencing to identify frequent mutations in the cyp51A gene [tandem repeat 46 (TR46), L98H, and M220 alterations] that confer azole resistance was performed.
Results:
Specific fungal DNA was identified in 31 (41.3%) FFPE samples, and of these, 16 samples of specific fungal DNA were in accord with a histopathological diagnosis of aspergillosis or mucormycosis; 15 samples had discordant histopathology and PCR results. No azole-mediating cyp51A gene mutation was noted among nine cases of aspergillosis. Moreover, no cyp51A mutations were identified among three cases with history of prior azole use.
Conclusion
Panfungal PCR assay with FFPE samples may provide additional information of use to fungal species identification. No azole-resistance mediating mutations in the A. fumigatus cyp51A gene were identified among FFPE samples during study period.
10.Emphysematous Gastritis Worsened after Upper Endoscopy
Tae Un KIM ; Su Jin KIM ; Hwaseong RYU ; Jin Hyeok KIM ; Joo Yeon JANG ; Jeong A YEOM ; Jieun ROH ; Hee Seok JEONG ; Byung Soo PARK ; Dong Il KIM
The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2020;20(1):73-76
Emphysematous gastritis is an infectious disease in which air is formed in the gastric wall by gas-forming organisms. It is infrequently reported but can be fatal without early diagnosis and treatment. The stomach is rarely infected because of the acidity of the gastric secretions and the rich blood supply. Treatment should be aimed at covering gram-negative organisms and anaerobes using broad-spectrum intravenous antibiotics, and occasional surgical management in order to enhance survival. Risk factors are those that lead to disrupted mucosal integrity, such as corrosive injury, and those that result in an immunosuppressed condition, including diabetes mellitus, chronic kidney disease, immunosuppressive drug use, and subsequent invasion by gas-forming organisms. We experienced a case of emphysematous gastritis that worsened after endoscopy. Aeration during upper endoscopy examination can cause barotrauma to the gastric wall with impairment of the mucosal barrier, resulting in the spread of gastric wall infection to the whole body. Therefore, we report this case and provide relevant literature review to suggest that early endoscopic evaluation can lead to exacerbation of emphysematous gastritis.

Result Analysis
Print
Save
E-mail